Stroke News

High BP in young adulthood may slightly increase the risk for CV events later in life, researchers found.

Smoking may increase the risk for fatal subarachnoid hemorrhage and potentially affect the familial manifestation of this event, researchers found in an analysis of the Finnish Twin Cohort.

Adverse pregnancy outcomes, particularly hypertensive disorders of pregnancy and low birth weight, were independently linked to atherosclerotic CVD in postmenopausal women, researchers found.

Patients with atrial fibrillation who received nonrecommended doses of direct oral anticoagulants had increased risk for death compared with those who received recommended doses, according to new data from the GARFIELD-AF registry.

Women with early-onset MI had fewer recurrent major CV events during long-term follow-up compared with men, despite sex differences regarding disease burden and preventive treatments, researchers found.

The most prevalent comorbidity in patients hospitalized for COVID-19 was hypertension, which was also a risk factor for acute kidney injury in the ED and mortality in these patients, researchers found in two separate studies.

Among patients 80 years or older, treatment of ACS with ticagrelor was associated with greater risk for death and bleeding compared with clopidogrel, researchers reported.

Autologous cell-based therapy in patients with acute MI may decrease HF hospitalization, according to the BAMI trial, which was converted to an observational trial due to low patient recruitment.

A higher dose of a glycoprotein VI inhibitor in patients with CAD who underwent PCI resulted in more pronounced platelet inhibition without increasing bleeding risk, researchers found in the ISAR PLASTER trial.

Patients who started or continued smoking after an atrial fibrillation diagnosis experienced greater risk for stroke compared with patients who quit or never smoked, researchers reported.